Associate Professor Francis is the Clinical Director of NCARD, leading a group of about 35 researchers and staff to conduct asbestos-related disease research. Roslyn’s specialty is in nuclear medicine, specifically medical imaging. Her areas of interest include novel molecular imaging and PET tracers. In addition to asbestos diseases, Roslyn is also active in oncology, cardiology, neurology and inflammatory disease.
Apart from her role at NCARD, Roslyn is the Deputy Director of the WA National Imaging Facility node. She was a co-founder of the Australian Centre for Quantitative Imaging and the Australasian Radiopharmaceutical Trials Network.